Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$386,334,992
-$82,213,840 QoQ
Shares Held
16,043,812
-3.8% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#40
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. PFE ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
This page
|
16,043,812 | $386,334,992 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $386,334,992 | 16,043,812 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $468,548,832 | 16,686,212 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $387,942,298 | 15,580,012 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $417,579,285 | 16,388,512 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $416,152,610 | 17,168,012 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $405,009,524 | 15,983,012 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $424,700,517 | 16,008,312 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $486,762,465 | 16,819,712 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $467,792,359 | 16,718,812 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $469,247,283 | 16,909,812 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $508,279,158 | 17,654,712 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $602,301,258 | 18,158,012 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $747,747,916 | 20,385,712 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $908,906,169 | 22,277,112 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,168,790,138 | 22,810,112 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,064,078,706 | 24,316,241 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,278,948,111 | 24,393,441 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,258,577,415 | 24,310,941 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,258,405,161 | 21,310,841 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $951,954,996 | 22,133,341 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $890,629,233 | 22,743,341 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $829,833,331 | 22,904,591 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $828,055,342 | 22,495,391 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $847,805,533 | 23,100,991 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $764,058,885 | 23,365,691 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $751,968,799 | 23,038,291 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||